What is a stock summary page? Click here for an overview.
Business Description
Medartis Holding AG
ISIN : CH0386200239
Share Class Description:
CHIX:MEDz: Ordinary SharesDescription
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from EMEA and also has a presence in APAC, USA, LATAM, and North America.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.05 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 4.15 | |||||
| Interest Coverage | 10.55 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.33 | |||||
| Beneish M-Score | -2.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.9 | |||||
| 3-Year EBITDA Growth Rate | 22.1 | |||||
| 3-Year Book Growth Rate | 4.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 192.11 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.57 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.01 | |||||
| 9-Day RSI | 69.15 | |||||
| 14-Day RSI | 62.77 | |||||
| 3-1 Month Momentum % | 5.85 | |||||
| 6-1 Month Momentum % | 26.22 | |||||
| 12-1 Month Momentum % | -7.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.52 | |||||
| Quick Ratio | 3.15 | |||||
| Cash Ratio | 2.23 | |||||
| Days Inventory | 622.6 | |||||
| Days Sales Outstanding | 71.42 | |||||
| Days Payable | 64.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.6 | |||||
| Shareholder Yield % | -4.54 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.53 | |||||
| Operating Margin % | 4.66 | |||||
| Net Margin % | 1.83 | |||||
| FCF Margin % | 6.92 | |||||
| ROE % | 1.53 | |||||
| ROA % | 1.03 | |||||
| ROIC % | 2.79 | |||||
| 3-Year ROIIC % | 2.09 | |||||
| ROC (Joel Greenblatt) % | 3.74 | |||||
| ROCE % | 1.71 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 249.25 | |||||
| Forward PE Ratio | 58.69 | |||||
| PE Ratio without NRI | 249.25 | |||||
| Shiller PE Ratio | 392.02 | |||||
| Price-to-Owner-Earnings | 56.87 | |||||
| PEG Ratio | 29.67 | |||||
| PS Ratio | 4.53 | |||||
| PB Ratio | 3.85 | |||||
| Price-to-Tangible-Book | 4.94 | |||||
| Price-to-Free-Cash-Flow | 63.38 | |||||
| Price-to-Operating-Cash-Flow | 30.38 | |||||
| EV-to-EBIT | 176.69 | |||||
| EV-to-Forward-EBIT | 67.95 | |||||
| EV-to-EBITDA | 35.27 | |||||
| EV-to-Forward-EBITDA | 25.18 | |||||
| EV-to-Revenue | 4.67 | |||||
| EV-to-Forward-Revenue | 3.96 | |||||
| EV-to-FCF | 66.8 | |||||
| Price-to-GF-Value | 0.7 | |||||
| Price-to-Projected-FCF | 6.13 | |||||
| Price-to-Peter-Lynch-Fair-Value | 182.26 | |||||
| Price-to-Graham-Number | 7.4 | |||||
| Price-to-Net-Current-Asset-Value | 15.88 | |||||
| Earnings Yield (Greenblatt) % | 0.57 | |||||
| FCF Yield % | 1.48 | |||||
| Forward Rate of Return (Yacktman) % | 7.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Medartis Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 220.282 | ||
| EPS (TTM) (CHF) | 0.31 | ||
| Beta | 1.94 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 32.12 | ||
| 14-Day RSI | 62.77 | ||
| 14-Day ATR (CHF) | 2.521751 | ||
| 20-Day SMA (CHF) | 72.125 | ||
| 12-1 Month Momentum % | -7.05 | ||
| 52-Week Range (CHF) | 45.5 - 82.1 | ||
| Shares Outstanding (Mil) | 13.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medartis Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medartis Holding AG Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medartis Holding AG Frequently Asked Questions
What is Medartis Holding AG(CHIX:MEDz)'s stock price today?
The current price of CHIX:MEDz is CHF76.55. The 52 week high of CHIX:MEDz is CHF82.10 and 52 week low is CHF45.50.
When is next earnings date of Medartis Holding AG(CHIX:MEDz)?
The next earnings date of Medartis Holding AG(CHIX:MEDz) is 2025-08-20 Est..
Does Medartis Holding AG(CHIX:MEDz) pay dividends? If so, how much?
Medartis Holding AG(CHIX:MEDz) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers